Human health risk assessment of 2-mercaptobenzothiazole in drinking water

Toxicology and Industrial Health

Volumn 20, Issue 10, 2004, Pages 149-163

  Whittaker, Margaret H ^a   Gebhart, Ann Marie ^b   Miller, Thea Clipson ^a   Hammer, Frank ^b  

^a ToxServices   (United States)

^b UNDERWRITERS LABORATORIES INC   (United States)

Author keywords

2 mercaptobenzothiazole; bladder cancer; drinking water; risk assessment; total allowable concentration; transitional cell tumours

Indexed keywords

2 MERCAPTOBENZOTHIAZOLE; DRINKING WATER;

ANIMAL CELL; BLADDER CANCER; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER RISK; CERTIFICATION; CHROMOSOME ABERRATION; CONTROLLED STUDY; DOSE RESPONSE; EVALUATION; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY PELVIS; LONG TERM EXPOSURE; METHODOLOGY; MOUSE; NONHUMAN; OCCUPATIONAL EXPOSURE; RAT; REVIEW; RISK ASSESSMENT; RUBBER INDUSTRY; SENSITIVITY ANALYSIS; TRANSITIONAL CELL CARCINOMA; WATER CONTAMINATION; WATER SUPPLY;

ANIMALS; BENZOTHIAZOLES; CARCINOGENICITY TESTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FRESH WATER; HUMANS; MAXIMUM ALLOWABLE CONCENTRATION; MICE; MODELS, BIOLOGICAL; MUTAGENICITY TESTS; RATS; RISK ASSESSMENT; SPECIES SPECIFICITY; THIAZOLES; WATER POLLUTANTS, CHEMICAL; WATER SUPPLY;

BACTERIA (MICROORGANISMS); MAMMALIA; ZEA MAYS;

EID: 18744396703     PISSN: 07482337     EISSN: None     Source Type: Journal    
DOI: 10.1191/0748233704th199oa     Document Type: Article

References (53)

1. American Chemistry Council (ACC). 2001: HPV Challenge Program submission benzothiazole-based thiazoles category.Retrievedfrom:http://www.epa.gov/chemrtk/bnzthict/c13324tc.htm
2. Anderson, B. E., Zeiger, E., Shelby, M. D. et al. 1990: Chromo-some aberration and sister chromatid exchange test results with 42 chemicals. Environmental and Molecular Mutagenesis 16, 55-137. Also accessible through the NTP on-line study database: http://ntp-apps.niehs.nih.gov/ntp_tox/index.cfm
3. Berufsgenossenschaft der chemischen Industrie (BUA GDCh Advisory Committee on Existing Chemicals). 2000: 2-Mercaptobenzothiazol. Number 70, www.gdch.de/taetigkeiter/bua/berichte.htm (last accessed December 04).
4. Bregman, C. L., Adler, R. R., Morton, D. G. et al. 2003: Recommended tissue list for histopathologic examination in repeat-dose toxicity and carcinogenicity studies: a proposal of the Society of Toxicologic Pathology (STP). Toxicologic Pathology 31, 252-253.
5. California Environmental Protection Agency (Cal-EPA). 2002: No significant risk level for the Proposition 65 carcinogen benzofuran. Reproductive and Cancer Hazard Assessment Section. Office of Environmental Health Hazard Assess-ment(OEHHA).Retrievedfrom:http://www.oehha.ca.gov/prop65/CRNR_notices/pdf_zip/BenzofuranNSRL%20_Aug%202002.pdf (last accessed December 04).
6. Chemical Manufacturers Association (CMA). 1989: Letter from Chemical Manufacturers Association to US EPA regarding information on the enclosed final reports on 2-mercaptobenzothiazole. EPA Doc. No. 40-8972396. Fiche No.OTS0525082. Summarized in TSCATS on-line record for 2-mercaptobenzothiazole. Retrieved from: http://esc.syrres.com/efdb/TSCATS.htm (last accessed December 04).
7. Collins, J. J., Strauss, M. E. and Riordan, S. G. 1999: Mortalities of workers at the Nitro plant with exposure to 2-mercaptobenzothiazole. Occupational and Environmenironmental Medicine 56, 667-671.
8. Corazza, M., Maranini, C., Venturini, D. and Virgili, A. 1999: Contact allergy to mercaptobenzothiazole in a bank clerk from a wet sponge. Contact Dermatitis 41, 105-106.
9. Crebelli, R., Paoletti, A., Falcone, E. et al. 1985: Mutagenicity studies in a tyre plant: in vitro activity of workers’ urinary concentrates and raw materials. British Journal of Industrial Medicine 42, 481-487.
10. Donner, M., Husgagvel-Pursianinen, K., Jenssen, D. and Rannug, A. 1983: Mutagenicity of rubber additives and curing fumes: results from five short-term bioassays. Scandinavian Journal of Work, Environment & Health 9, 27-37.
11. El Dareer, S. M., Kalin, J. R., Tillery, K. F. et al. 1989: Disposition of 2-mercaptobenzothiazole and 2-mercapto-benzothiazole disulfide in rats dosed intravenously, orally, and topically and in guinea pigs dosed topically. Journal of Toxicology and Environmental Health 27, 65-84.
12. Feron, V. J., Schwarz, M., Hemminki, K. and Krewski, D. 1999: Long- and medium-term carcinogenicity studies in animals and short-term genotoxicity tests. In Moolgavkar, S., Krewski, D., Zeise, L., Cardis, E. and Moller, H., editors, Quantitative estimation and predication of human cancer risks. Lyon: IARC Press, 103-129.
13. Fukuoka, M. and Tanaka, A. 1987: The metabolic origin of the sulfur atom in the sulfhydryl group of 2-thioben-zothiazole. Archives of Toxicology 61, 158-160.
14. Goodyear. 1980: Mutagenicity evaluation of Captax. Summarized in BUA, 2000.
15. Hamlin, M. H. and Banas, D. A. 1990: Adrenal gland. In Boornman, G. A., Eustis, S. L., Elwell, M. R., Montgomery, C. A. and Mackenzie, W. F., editors, Pathology of the Fischer rat: reference and atlas, New York, NY: Academic Press, 501-517.
16. Hardin, B. D., Bond, G., Sikov, M. R. et al. 1981: Testing of selected workplace chemicals for teratogenic potential. Scandinavian Journal of Work, Environment & Health 7, 66-75.
17. Haseman, J. K., Hailey, J. R. and Morris, R. W. 1998: Spontaneous neoplasm incidences in Fischer 344 rats and B6C3F1 mice in two-year carcinogenicity studies: a National Toxicology Program update. Toxicologic Pathology 26, 428-441.
18. Hazardous Substance Databank (HSDB). 2004: 2-Mercapto-benzothiazole on-line record http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?HSDB (last accessed December 04).
19. Hennekens, C. H. and Buring, J. E. 1987: In Mayrent, S. L., editor, Epidemiology in medicine. Boston, MA: Little, Brown.
20. Innes, J. R. M., Ulland, B. M., Valerio, M. G. et al. 1969: Bioassay of pesticides and industrial chemicals for tumor-igenicity in mice: a preliminary note. Journal of the National Cancer Institute 42, 1101-1114.
21. Jokinen, M. P. 1990: Urinary bladder, ureter, and urethra. In Boornman, G. A., Eustis, S. L., Elwell, M. R., Montgomery, C. A. and Mackenzie, W. F., editors. Pathology of the Fischer rat: reference and atlas. New York, NY: Academic Press, 109-126.
22. La Vecchia, C. and Airoldi, L. 1999: Human bladder cancer: epidemiological, pathological, and mechanistic aspects. IARC Scientific Publications 147, 139-157. Retrieved from: http://monographs.iarc.fr/htdocs/iarcpubs/pub147/pub147consensus.html (last accessed December 04).
23. Litton. 1985: Report to the Chemical Manufacturer's Association. Summarized in NTP, 1988. Study ID 920542. Accessed through the NTP on-line study database: http://ntp-server.niehs.nih.gov/Main_Pages/SearchData.html
24. McConnell, E., Solleveid, H. A., Swenberg, J. A. and Boorman, G. A. 1986: Guidelines for combining neoplasms for evaluation of rodent carcinogenesis studies. Journal of the National Cancer Institute 76, 283-289.
25. Myhr, B., McGregor, D., Bowers, L. et al. 1990: L5178 mouse lymphoma cell mutation assays results with 41 compounds. Environmental and Molecular Mutagenesis 16, 138-167.
26. National Toxicology Program (NTP). 1988: NTP technical report on the toxicology and carcinogenesis studies of 2-mercaptobenzothiazole in F344 rats and B6C3F1 mice (gavage studies). Technical Report Series. TR-332. Accessed through the NTP on-line study database: http://ntp-apps.niehs.nih.gov/ntp_tox/index.cfm (last accessed December 04).
27. National Toxicology Program (NTP). 1993: Micronucleus test of 2-mercaptobenzothiazole. Study ID A62048. Accessed through the NTP on-line study database: http://ntp-apps.niehs.nih.gov/ntp_tox/index.cfm (last accessed December 04).
28. National Toxicology Program (NTP). 1999: NTP historical control information for the NIH-07 diet. Retrieved from: http://ehp.niehs.nih.gov/ntp/docs/ntp_hcrs.html (last accessed December 04).
29. National Institute of Occupational Safety and Health (NIOSH). 1989: National Occupational Exposure Survey. Cited in the HSDB online record for 2-mercaptoben-zothiazole.
30. National Sanitation Foundation (NSF). 2003: Standard 61: Drinking Water System Components-Health Effects. Available for purchase at www.nsf.org (last accessed January 05).
31. Ogawa, Y., Kamata, E., Suzuki, S. et al. 1989: Toxicity of 2-mercaptobenzothiazole in mice. Bull Natl Inst Hyg Sci 107, 44-50, summarized in ACC, 2001. Retrieved from: http://www.epa.gov/chemrtk/bnzthict/c13324rs.pdf (last accessed December 04).
32. Peto, R. 1974: Guidelines on the analysis of tumor rates and death rates in experimental animals. British Journal of Cancer 29, 101-105.
33. Peto, R., Pike, M. C., Day, N. E. et al. 1980: Guidelines for simple, sensitive significance tests for carcinogenic effects in long-term animal experiments. In IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans, Suppl. 2. IARC Press, 311-346.
34. Peto, R., Pike, M. C., Berstein, L. et al. 1984: The TD50: a proposed general convention for the numerical description of the carcinogenic potency of chemicals in chronic-exposure animal experiments. Environmental Health Perspectives 58, 1-8. Retrieved from: http://potency.berkeley.edu/pdfs/Peto1984.pdf (last accessed December 04).
35. Pharmakon Research. 1984: Report to the Chemical Manufacturer's Association. Described in NTP, 1988 and BUA, 2000.
36. Ritchie, A. C. 1990: Urinary tract. In Boyd's textbook of pathology, Volume II, ninth edition. Philadelphia, PA: Lea and Febiger.
37. Roed-Petersen, J., Hjorth, N., Jordan, W. P. and Bourlas, M. 1977: Postsorters’ rubber fingerstall dermatitis. Contact Dermatitis 3, 143-147.
38. Sorahan, T. and Pope, D. 1993: Mortality study of workers employed at a plant manufacturing chemicals for the rubber industry: 1955-1986. British Journal of Industrial Medicine 50, 998-1002.
39. Sorahan, T., Hamilton, L. and Jackson, J. R. 2000: A further cohort study of workers employed at a factory manufacturing chemicals for the rubber industry, with special emphasis to the chemicals 2-mercaptobenzothia-zole (MBT), aniline, phenyl-b-naphthylamine and o-tolui-dine. Occupational and Environmental Medicine 57, 106-115.
40. Springborn Laboratories. undated: Study No. 3205.5. Jointly sponsored through the Chemical Manufacturer's Association as part of a TSCA Section 4 test rule. Summarized in ACC, 2001.
41. Stefanski, S. A. 1990: Spleen, lymph nodes and thymus. In Boorman, G. A., Eustis, S. L., Elwell, M. R., Montgomery, C. A. and Mackenzie, W. F., editors, Pathology of the Fischer rat: reference and atlas. New York, NY: Academic Press, 369-393.
42. Strauss, M. E., Barrick, E. D. and Bannister, R. M. 1993: Mortality experience of employees exposed to 2-mercap-tobenzothiazole at a chemical plant in Nitro, West Virginia. British Journal of Industrial Medicine 50, 888-893.
43. Toxic Substances Control Act Database (TSCATS). 2003: 2-Mercaptobenzothiazole. http://esc.syrres.com/efdb/TSCATS.htm (last accessed December 04).
44. US Environmental Protection Agency (US EPA). 1988: Recommendations for and documentation of biological values for use in risk assessment. EPA/600/6-87/008. NTIS PB88179874.
45. US Environmental Protection Agency (US EPA). 1999a: Draft revised guidelines for carcinogen risk assessment. Washington, DC: Risk Assessment Forum. NCEAF-0644. Retrieved from: http://cfpub2.epa.gov/ncea/raf/cancer.cfm (last accessed December 04).
46. US Environmental Protection Agency (US EPA). 1999b: RAGS 3A: process for conducting probabilistic risk assessment. Chapter 1: basic concepts of probabilistic risk assessment. Section 3.5. Retrieved from: http://www.epa.gov/superfund/programs/risk/rags3adt/chapters.pdf (last accessed December 04).
47. US Environmental Protection Agency (US EPA). 2000a: Benchmark dose technical guidance manual. EPA/630/R-00/001. Retrieved from: http://www.epa.gov/ncea/pdfs/bmds/BMD-External_10_13_2000.pdf (last accessed December 04).
48. US Environmental Protection Agency (US EPA). 2000b: Methodology for deriving ambient water quality criteria for the protection of human health. Technical support document. Volume 1: risk assessment. Retrieved from: http://www.epa.gov/waterscience/humanhealth/method/supportdoc.pdf (last accessed December 04).
49. US Environmental Protection Agency (US EPA). 2003a: Draft final guidelines for cancer risk assessment. Retrieved from: http://cfpub.epa.gov/ncea/raf/recordisplay.cfm?deid/55868 (last accessed December 04).
50. US Environmental Protection Agency (US EPA). 2003b: Benchmark dose software. Version 1.3.2. Retrieved from: http://cfpub2.epa.gov/ncea/cfm/recordisplay.cfm?deid-20167 (last accessed December 04).
51. US Environmental Protection Agency (US EPA). 2004: Toxicological review for 1,2-dibromoethane. Integrated Risk Information System (IRIS). Office of Research and Development. Retrieved from: http://www.epa.gov/iris/toxreviews/0361-tr.pdf (last accessed December 04).
52. Williams, T.M., Hickey, J.L.S. and Bishop, C.C. 1984: Health hazard evaluation report No. HETA-83-196-1492. Gadsden, AL: Goodyear Tire and Rubber Company. Hazard Evaluations and Technical Assistance Branch, NIOSH, US Department of Health and Human Services, Cincinnati, OH, Report No. HETA-83-196-1492.
53. Yamaguchi, T., Yamauchi, A., Yamazaki, H. and Kakiuchi, Y. 1991: Mutagenicity of rubber additives in tire. Eisei Kagaku 37, 6-13.